Archive: 09/10/2013

Adempas approved to treat pulmonary hypertension

(HealthDay)—Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.

South Africa winning malaria fight with DDT help: report

South Africa has turned the tide on malaria, cutting mortality rates by 85 percent over the last 12 years, and hopes to soon eliminate the disease, a report stated Wednesday amid controversy over the use of highly controversial ...

Why we can't accurately judge our friends' behavior

There is no such thing as objectivity when it comes to your friends: According to a new study, people evaluate their friends' behavior more positively than do strangers, regardless of actual performance on a series of tasks. ...

Big data reaps big rewards in drug safety

Using the Food and Drug Administration's Adverse Event Reporting System (FAERS), a hospital electronic health records database, and an animal model, a team of researchers at the Icahn School of Medicine at Mount Sinai report ...

Using stem cells to promote nerve regeneration

Johns Hopkins researchers from the Department of Plastic and Reconstructive Surgery report that a type of stem cell found easily in fat cells and also in bone marrow promoted nerve regeneration in rats with paralyzing leg ...

page 3 from 9